Skip to content
Search

Latest Stories

LloydsPharmacy offers pharmacist-led Covid vaccines at Carterton and Cramlington

Two months after launching its first site in January, McKesson UK, the parent company of LloydsPharmacy, has started offering Covid-19 jabs in two more pharmacist-led sites as NHS England revised its vaccination criteria.

Covid-19 vaccinations began on Monday (March 22) with pharmacists at the multiple's Carterton and Cramlington branches aiming to administer a minimum of 400 doses of the Oxford-AstraZeneca vaccine per week to eligible patients in the local area.


LloydsPharmacy believes increasing the number of community pharmacies involved in vaccination programme will help improve ease of access and reduce the distance some people will need to travel, enabling those that are most vulnerable to get the vaccine quickly and conveniently.

Anna Ruthven, head of services at McKesson UK, said: “Throughout this pandemic pharmacy teams have demonstrated what an asset they are to the healthcare system in this country. Our LloydsPharmacy colleagues, like so many others, have been ready and willing to support this monumental programme from the start so today marks a real milestone for everyone involved.

"It has been a massive team effort to mobilise these new sites in a very short space of time, but we’re all so proud to be helping local communities get this important vaccine. Community is at the heart of what we do, and we hope that delivering the vaccine within a local and trusted healthcare setting will help even more people come forward to get the jab when they are asked to.”

The Covid-19 vaccines will be administered by appointment only to priority group patients in a consultation room at Carterton and a special pod at Cramlington.

Appointments are made via the NHS booking system with both sites already fully booked for the first two weeks.

Karen Bailey, site manager at LloydsPharmacy Carterton, commented: “Our pharmacy is embedded in the local community and having a familiar face to administer the vaccine will make a big difference to patients who are perhaps nervous about travelling to larger vaccination sites that they’ve not been to before.

"It’s been a busy couple of weeks getting the pharmacy ready for the launch but the whole team is excited to be one of the first LloydsPharmacy teams involved. The light at the end of the tunnel is getting closer and we’re so proud to be helping protect people from this virus so we can all get back to seeing the people we love and doing the things we miss the most.”

McKesson UK's first Covid-19 vaccination was launched in London at John Bell & Croyden on January 30. The site has administered 6,875 vaccines so far.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less